Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age
about
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]Syndromic gastrointestinal stromal tumorsSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsRare Tumors in Children: Progress Through CollaborationPersonalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisNovel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumorsConnecting molecular pathways to hereditary cancer risk syndromesMolecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications.Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).MDCT features of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumours.SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumorsSuccinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.Succinate dehydrogenase-deficient gastrointestinal stromal tumors.The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelinesA multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.Gastrointestinal stromal tumor - an evolving concept.Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST).KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.Soft-Tissue Sarcomas of the Abdomen and Pelvis: Radiologic-Pathologic Features, Part 1-Common Sarcomas: From the Radiologic Pathology Archives.State of the Art in the Treatment of Gastrointestinal Stromal Tumors.A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma.Plexiform myxoid gastrointestinal stromal tumor: a potential diagnostic pitfall in pathological findings.Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutationGene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors.Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature.Surgical treatment of gastric gastrointestinal stromal tumorMolecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.Brunner's gland cyst in combination with gastrointestinal stromal tumor: A case report.Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.Succinate dehydrogenase expression in breast cancer.
P2860
Q21133528-9E1FA959-BF8F-4405-BBD8-A6FD717C19D8Q26738882-A1CA451A-D589-4195-9B44-DEBE87B8433EQ26796203-A883513F-7884-4072-B03A-A37EF8ED6573Q26797511-7A877356-2F92-44F8-8190-D3952DCF6819Q26800005-78055128-78AB-4008-A2D8-46292DC43312Q27001114-ECE25DA6-3320-4931-B965-1659CEA2D24AQ28291516-C8B8A566-E4E9-42E7-BCA3-6CE536919074Q30245586-B666689E-0AD3-4D2C-B669-34B98F554106Q33633409-AF8435FD-7561-4F1E-97D9-62CE8E7BE1DAQ33722723-99871EFF-63A4-4EE2-B970-421A49552C4AQ33954761-F695844E-E803-47CD-9301-A948EC28D008Q34274467-72331A09-F65B-4EBC-A4CD-7E0CF385E85BQ34392125-89C5CE3C-08BB-4970-AA00-4A7A265F2C5CQ34413881-DBEBB9C9-A73B-41CB-B40B-B9F2383B0C50Q34498417-33D76404-82F3-430D-9B26-E6248762DA36Q34660467-75567029-78CE-47B1-BB34-F4E1721B0536Q34668378-B77C8FF1-2A3D-422B-A3EA-693BB0B0252EQ34672344-C19F0D93-1D44-4F97-9CE6-AB13AC47D37AQ34737119-DD0AFF10-BFD1-425F-9DCB-63D725B3DD15Q34928165-1E3471EE-515D-457F-9141-F7B25FD1D071Q35258231-6DE57F54-E897-4992-8196-9E78356ED773Q35671824-7FA719C9-881C-48BD-A1A6-7C70D5F4250FQ36025994-86EAE337-988F-4B34-B82A-7D51903C5289Q36125976-B0531085-C4BB-421F-9332-F5E0FCEDEA91Q36306083-906D20BE-BBEC-4226-8977-4D1E5A23ABC8Q36344557-AD7E3DE6-03AC-4798-B50B-35EA9EB49DF2Q36375056-027B26B2-ABC3-48D2-9228-6CDD053E4FBFQ36375596-84D46A24-B584-4DE4-A641-703298353D93Q36412898-15266CCF-13EE-4CB5-8ABB-5F8EFFA1A213Q36509363-21BEED6D-9988-4C56-98DE-C6FBC0687F80Q36532675-9CEB8A1E-9569-4F1F-985C-B290759C40F6Q36577759-C585BFD9-771C-493C-B72A-2F70A9C72DE6Q36587153-D3DA3E69-2E39-4BB1-A9A6-CB4E0329171BQ36589296-BF05161F-0EE7-42D8-A3D8-078E0C33B3FBQ36640481-D1929673-E949-4C33-821F-2D9C4082DC76Q36770203-A801C715-EF05-4320-BD41-0DDC06A73D97Q36809668-5DB4F39C-93F9-418C-8BEC-703699BC1BDFQ36826027-221ECED5-B5EE-47FD-A767-4F90E8863B2AQ36850606-F8D42CB3-BDE9-4F34-997C-D3431598F749Q37009756-E9C3754E-2CAE-403A-89D9-E1897FB1E6C0
P2860
Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Succinate dehydrogenase-defici ...... with predilection to young age
@ast
Succinate dehydrogenase-defici ...... with predilection to young age
@en
type
label
Succinate dehydrogenase-defici ...... with predilection to young age
@ast
Succinate dehydrogenase-defici ...... with predilection to young age
@en
prefLabel
Succinate dehydrogenase-defici ...... with predilection to young age
@ast
Succinate dehydrogenase-defici ...... with predilection to young age
@en
P2093
P2860
P1476
Succinate dehydrogenase-defici ...... with predilection to young age
@en
P2093
Czeslaw Osuch
Jerzy Lasota
Maarit Sarlomo-Rikala
Markku Miettinen
Zeng-Feng Wang
P2860
P304
P356
10.1097/PAS.0B013E3182260752
P407
P577
2011-11-01T00:00:00Z